Skip to content

Newborn neuroprotection trials report promising but incomplete evidence

A review in lower-income settings reported favorable survival and neurological findings, but missing effect estimates and limited developmental data leave major uncertainty.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

The review reported improved survival with melatonin and favorable short-term neurological outcomes across the medicines studied in newborns with perinatal asphyxia. Developmental results were generally favorable but limited. Without effect estimates or uncertainty intervals in the abstract, these signals cannot establish the size of benefit or which medicine, if any, is the most effective.

Keep in mind

The abstract does not report medicine-specific sample sizes, effect estimates, confidence intervals or adverse events. Most trials were conducted in Asia, and limited developmental data constrain conclusions about longer-term outcomes across the settings of interest.

THE RESULT, WITH CONTEXT

What researchers found

Improved survival reported

Melatonin in newborns with perinatal asphyxia

Versus placebo or standard care in the included trials; survival assessment timing and effect estimates were not reported.

PLoS One, 2025 · Original source ↓

What was actually compared

The eligible trials compared medicines with placebo or standard care and excluded therapeutic hypothermia. The review therefore does not directly establish whether any drug can match or replace cooling treatment.

Developmental evidence remained limited

Follow-up results generally favored treatment, but the abstract describes the developmental data as limited. It does not supply separate estimates by medicine and assessment time, preventing a detailed judgment about sustained neurological benefit.

CHECK THE ORIGINAL

The original publication

Pharmacologic neuroprotective agents for the treatment of perinatal asphyxia in low-income and lower-middle-income countries: A systematic review and meta-analysis of randomised controlled trials.

Ayeni VA, Abdullahi AA, Isah A et al.
PLoS One · 2025

PubMed ID
41343532
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.